APA (7th ed.) Citation

Qiu, Y., Jacobs, D. M., Messer, K., Salmon, D. P., Wellington, C. L., Stukas, S., . . . Ala, T. (2025). Prognostic value of plasma biomarkers for informing clinical trial design in mild-to-moderate Alzheimer's disease. Alzheimer's Research & Therapy, 17(1), 1. https://doi.org/10.1186/s13195-025-01745-3

Chicago Style (17th ed.) Citation

Qiu, Yuqi, et al. "Prognostic Value of Plasma Biomarkers for Informing Clinical Trial Design in Mild-to-moderate Alzheimer's Disease." Alzheimer's Research & Therapy 17, no. 1 (2025): 1. https://doi.org/10.1186/s13195-025-01745-3.

MLA (9th ed.) Citation

Qiu, Yuqi, et al. "Prognostic Value of Plasma Biomarkers for Informing Clinical Trial Design in Mild-to-moderate Alzheimer's Disease." Alzheimer's Research & Therapy, vol. 17, no. 1, 2025, p. 1, https://doi.org/10.1186/s13195-025-01745-3.